QA: Briacell Therapeutics Corp in us_pharma/2025

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001610820_2026_Briacell_Therapeutics_Corp.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001610820, Briacell Therapeutics Corp

  xvar xval
0 AssetsCurrent 19,926,576
1 IntangibleAssetsNetIncludingGoodwill 184,525
2 PropertyPlantAndEquipmentNet 296,819
3 remainder_Assets 1,241,786
4 LiabilitiesCurrent 3,977,988
5 LiabilitiesNoncurrent 337,672
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 5,934,125
9 ResearchAndDevelopmentExpense 21,270,678
10 remainder_Expenses -758,364
11 remainder_Revenues 0
12 remainder_NetIncome -109,701
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 21,649,706
1 Liabilities 4,315,660
2 Expenses 26,446,439
3 Revenues 0
4 StockholdersEquity 17,334,046
5 NetIncome -26,556,140
6 ComprehensiveNetIncome -26,556,140
7 BaseVar 26,260,753
8 EconomicCapitalRatiobeforeLimitedLiability 0.865
9 EconomicCapitalRatio 2.19

Edgar->Model Mapping

Feature Distribution

Change over Time